Interestingly, transcription of LTR elements appeared more distinct between the conditions, with the exception of T1D, than overall gene expression, with a particularly strong signature in the IFNβ-treated subset of MS patients (Figure 4). This evidence concerns the gene IFNB1 and myeloid sarcoma.